258 related articles for article (PubMed ID: 27184936)
1. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
2. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
3. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
[TBL] [Abstract][Full Text] [Related]
4. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis.
Cakır Madenci Ö; Yakupoğlu S; Benzonana N; Yücel N; Akbaba D; Orçun Kaptanağası A
Burns; 2014 Jun; 40(4):664-9. PubMed ID: 24074718
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
[TBL] [Abstract][Full Text] [Related]
9. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.
Ali FT; Ali MA; Elnakeeb MM; Bendary HN
Clin Chim Acta; 2016 Sep; 460():93-101. PubMed ID: 27353646
[TBL] [Abstract][Full Text] [Related]
10. The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
Cerasi S; Leardini D; Lisanti N; Belotti T; Pierantoni L; Zama D; Lanari M; Prete A; Masetti R
Sci Rep; 2023 Apr; 13(1):6464. PubMed ID: 37081067
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
12. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
13. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.
Sargentini V; Ceccarelli G; D'Alessandro M; Collepardo D; Morelli A; D'Egidio A; Mariotti S; Nicoletti AM; Evangelista B; D'Ettorre G; Angeloni A; Venditti M; Bachetoni A
Clin Chem Lab Med; 2015 Mar; 53(4):567-73. PubMed ID: 24897401
[TBL] [Abstract][Full Text] [Related]
14. Pathfast presepsin assay for early diagnosis of systemic inflammatory response syndrome in patients with nephrolithiasis.
Hou YS; Wang H; Chen H; Wu LF; Lu LF; He Y
Biomed Res Int; 2015; 2015():792572. PubMed ID: 25722986
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
19. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
Takahashi W; Nakada TA; Yazaki M; Oda S
Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
